Alderaan Biotechnology

Alderaan Biotechnology is a biotechnology company developing antibodies targeting new and original objectives in immuno-oncology. The mission of Alderaan Biotechnology is to develop novel cancer therapies by targeting immune system cells. Alderaan Biotechnology's projects are related to the depletion of regulatory T cells and the hyperactivation of natural killer cells within the tumor microenvironment.